
Zentalis Pharmaceuticals Inc
ZNTLNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$4.07
Day High
$4.10
Day Low
$3.94
Prev. Close
$4.05
VolumeShares traded today.
518.61K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$284.75M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-2.30
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$6.95
52W LowLowest price over the past 52 weeks.
$1.13
50D MAAverage closing price over the last 50 trading days.
$3.78
200D MAAverage closing price over the last 200 trading days.
$2.36
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-3.4%1M
+1.0%6M
+177.8%YTD
+192.0%1Y
+230.6%About
Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.
www.zentalis.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade ZNTL
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.